Swiss National Bank Akero Therapeutics, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 94,500 shares of AKRO stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,500

Previous 102,000 7.35%

Holding current value

$3.02 Million

Previous $2.39 Million 13.34%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$21.45 - $29.34 $160,875 - $220,050	-7,500 Reduced 7.35%	94,500 $2.71 Million
Q2 2024 Aug 08, 2024	SELL	$18.31 - $24.62 $54,929 - $73,860	-3,000 Reduced 2.86%	102,000 $2.39 Million
Q1 2024 May 07, 2024	BUY	$17.76 - $31.18 $309,024 - $542,532	17,400 Added 19.86%	105,000 $2.65 Million
Q4 2023 Feb 06, 2024	SELL	$11.38 - $50.33 $110,386 - $488,201	-9,700 Reduced 9.97%	87,600 $2.05 Million
Q3 2023 Nov 08, 2023	BUY	$41.19 - $52.25 $41,190 - $52,250	1,000 Added 1.04%	97,300 $4.92 Million
Q2 2023 Aug 09, 2023	BUY	$36.89 - $56.88 $1.13 Million - $1.75 Million	30,700 Added 46.8%	96,300 $4.5 Million
Q1 2023 May 10, 2023	SELL	$37.27 - $50.24 $201,258 - $271,296	-5,400 Reduced 7.61%	65,600 $2.51 Million
Q4 2022 Feb 08, 2023	BUY	$33.44 - $54.8 $60,191 - $98,640	1,800 Added 2.6%	71,000 $3.89 Million
Q3 2022 Nov 09, 2022	BUY	$10.15 - $34.05 $200,970 - $674,190	19,800 Added 40.08%	69,200 $2.36 Million
Q2 2022 Aug 09, 2022	BUY	$8.0 - $15.01 $98,400 - $184,623	12,300 Added 33.15%	49,400 $467,000
Q1 2022 May 09, 2022	BUY	$12.97 - $22.26 $35,019 - $60,102	2,700 Added 7.85%	37,100 $526,000
Q2 2021 Aug 06, 2021	SELL	$24.81 - $32.35 $22,329 - $29,115	-900 Reduced 2.55%	34,400 $853,000
Q4 2020 Feb 05, 2021	BUY	$25.12 - $29.89 $17,584 - $20,923	700 Added 2.02%	35,300 $911,000
Q3 2020 Nov 09, 2020	BUY	$30.79 - $39.92 $375,638 - $487,024	12,200 Added 54.46%	34,600 $1.07 Million
Q2 2020 Aug 05, 2020	BUY	$19.25 - $26.76 $431,200 - $599,424	22,400 New	22,400 $558,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.49B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Akero Therapeutics, Inc. Transaction History